QQ客服 官方微博 反馈留言

	In silico prediction and in vitro and in vivo validation of acaricide fluazuron as a potential inhibitor of FGFR3 and a candidate anticancer drug for bladder carcinoma
	Ke, Kunbin; Li, Hongjian; Yao, Hong; Shi, Xi-Nan; Dong, Chao; Zhu, Ying; Liu, Xu; Li, Ling; Leung, Kwong-Sak; Wong, Man-Hon
刊名	CHEMICAL BIOLOGY & DRUG DESIGN
	2017
卷号	89期号:4
关键词	bladder carcinoma cancer therapy drug repurposing FGFR3 inhibition Fluazuron
ISSN号	1747-0277
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3423269
专题	昆明医科大学
推荐引用方式 GB/T 7714	Ke, Kunbin,Li, Hongjian,Yao, Hong,et al. In silico prediction and in vitro and in vivo validation of acaricide fluazuron as a potential inhibitor of FGFR3 and a candidate anticancer drug for bladder carcinoma[J]. CHEMICAL BIOLOGY & DRUG DESIGN,2017,89(4).
APA	Ke, Kunbin.,Li, Hongjian.,Yao, Hong.,Shi, Xi-Nan.,Dong, Chao.,...&Lin, Marie Chia-mi.(2017).In silico prediction and in vitro and in vivo validation of acaricide fluazuron as a potential inhibitor of FGFR3 and a candidate anticancer drug for bladder carcinoma.CHEMICAL BIOLOGY & DRUG DESIGN,89(4).
MLA	Ke, Kunbin,et al."In silico prediction and in vitro and in vivo validation of acaricide fluazuron as a potential inhibitor of FGFR3 and a candidate anticancer drug for bladder carcinoma".CHEMICAL BIOLOGY & DRUG DESIGN 89.4(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。